HGWM
CRL icon

Harvest Group Wealth Management’s Charles River Laboratories CRL Stock Holding History

Harvest Group Wealth Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-8
Closed -$1K – 588
2019
Q4 		$1K Hold
8
– – ﹤0.01% 742
2019
Q3 		$1K Buy
+8
New +$1.07K ﹤0.01% 840

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Harvest Group Wealth Management's CRL Position: Q1 2020 in Review

Harvest Group Wealth Management sold out of Charles River Laboratories (CRL) in Q1 2020, closing a stake of 8 shares — an estimated $1K sold.

Harvest Group Wealth Management first reported a position in CRL in Q3 2019 and held it in 2 quarters. The position peaked at $1K in Q4 2019. 414 funds tracked by Wall St. Rank hold CRL as of Q1 2020.

  • Harvest Group Wealth Management reported no remaining Charles River Laboratories position as of Q1 2020 after selling out during the quarter.
  • Harvest Group Wealth Management sold 8 Charles River Laboratories shares in Q1 2020, an estimated $1K.
  • Harvest Group Wealth Management first reported a position in Charles River Laboratories in Q3 2019 and held it in 2 quarters.
  • Harvest Group Wealth Management's Charles River Laboratories position peaked at $1K in Q4 2019.
  • 414 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2020.

Based on Harvest Group Wealth Management's 13F filing for Q1 2020, filed 23 Apr 2020.